RLAY - Relay Therapeutics slides on pricing ~$300.0M stock offering
- Relay Therapeutics ( NASDAQ: RLAY ) is down 2.78% after-hours on pricing an underwritten public offering of 11,320,755 shares of its common stock at a public offering price of $26.50/share for expected gross proceeds to be ~$300.0M.
- Underwriters are granted a 30-day option to purchase up to an additional 1,698,113 shares of its common stock.
- All of the shares in the offering are to be sold by Relay Therapeutics.
- Offering is expected to close on or about September 15, 2022.
- Earlier, Relay Therapeutics commences underwritten public offering of $300M shares .
For further details see:
Relay Therapeutics slides on pricing ~$300.0M stock offering